69 related articles for article (PubMed ID: 32096456)
1. The effect of cefoperazone sulbactam and piperacillin tazobactam on mortality in Gram-negative nosocomial infections.
Guclu E; Kaya G; Ogutlu A; Karabay O
J Chemother; 2020 May; 32(3):118-123. PubMed ID: 32096456
[TBL] [Abstract][Full Text] [Related]
2.
Xiao S; Zhuo C; Zhuo C
Comput Math Methods Med; 2021; 2021():1175379. PubMed ID: 34868336
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of antibiotic concentrations in drug dispensing in neonates: a laboratory-based study.
Zheng LY; Gu WP; Liang N; Gao LL; Guo WW; Li RR; Wang X; Hao GX; Van Den Anker J; Wu YE; Zhao W
BMJ Paediatr Open; 2023 Dec; 7(1):. PubMed ID: 38114241
[TBL] [Abstract][Full Text] [Related]
4. [A single-center study on the distribution and antibiotic resistance of pathogens causing bloodstream infection in patients with hematological malignancies].
Cai LJ; Wei XL; Wei YQ; Guo XT; Jiang XJ; Zhang Y; Yu GP; Dai M; Ye JY; Zhou HS; Xu D; Huang F; Fan ZP; Xu N; Shi PC; Xuan L; Feng R; Liu XL; Sun J; Liu QF
Zhonghua Xue Ye Xue Za Zhi; 2023 Jun; 44(6):479-483. PubMed ID: 37550203
[No Abstract] [Full Text] [Related]
5. Investigation and Analysis of Infection among Inpatients in a Tertiary Hospital in Shanghai.
Yu J; Wang J; Fang X; Huang F
Comput Math Methods Med; 2022; 2022():1157083. PubMed ID: 35799633
[TBL] [Abstract][Full Text] [Related]
6. Role of the gut microbiota in cefoperazone/sulbactam-induced epilepsy in mice with chronic renal failure.
Wu Y; Gu D; Li J; Li J; Hou G
Ren Fail; 2024 Dec; 46(2):2371551. PubMed ID: 38938213
[TBL] [Abstract][Full Text] [Related]
7. Piperacillin-tazobactam as the unusual cause of fever in a young male with an amoebic liver abscess.
Mangal V; Singh R
Indian J Pharmacol; 2024 Mar; 56(2):144-145. PubMed ID: 38687318
[No Abstract] [Full Text] [Related]
8. Efficacy and safety of generic cefoperazone/sulbactam versus branded cefoperazone/sulbactam in the treatment of bacterial infections: a systematic review and meta-analysis.
Wu R; Wang X; Cui P; Chen W; Yang W; Lai Y
J Chemother; 2024 Apr; ():1-11. PubMed ID: 38644652
[TBL] [Abstract][Full Text] [Related]
9. A case of
Wu L; Ye T; Pan X; Hong L; Shi Y
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 53(1):126-130. PubMed ID: 38105675
[TBL] [Abstract][Full Text] [Related]
10. Piperacillin-tazobactam compared with ampicillin-gentamicin for intraamniotic infection: a noninferior and propensity-matched analysis.
Anderson K; Scarpaci M; Hardy E; Li C; Lewkowitz AK; Rouse DJ; Polnaszek BE
Am J Obstet Gynecol; 2024 Jul; 231(1):e9-e11. PubMed ID: 38423449
[No Abstract] [Full Text] [Related]
11. Piperacillin-Tazobactam vs Cefoxitin Prophylaxis for Pancreatoduodenectomy.
Sawyer RG
JAMA; 2023 Sep; 330(11):1098-1099. PubMed ID: 37721617
[No Abstract] [Full Text] [Related]
12. Piperacillin-Tazobactam vs Cefoxitin Prophylaxis for Pancreatoduodenectomy.
Yang Z; Mei J; Gong W
JAMA; 2023 Sep; 330(11):1098. PubMed ID: 37721616
[No Abstract] [Full Text] [Related]
13. Piperacillin-Tazobactam vs Cefoxitin Prophylaxis for Pancreatoduodenectomy.
Jouffroy R; Lupinacci RM; Dournon N
JAMA; 2023 Sep; 330(11):1097-1098. PubMed ID: 37721615
[No Abstract] [Full Text] [Related]
14. Piperacillin-Tazobactam vs Cefoxitin Prophylaxis for Pancreatoduodenectomy-Reply.
Ellis RJ; Ko CY; D'Angelica MI
JAMA; 2023 Sep; 330(11):1099-1100. PubMed ID: 37721612
[No Abstract] [Full Text] [Related]
15. Safety of Tigecycline in Patients on Antithrombotic Therapy: A Single-Center Retrospective Study.
Lin C; Tan M; Wang D; Gu C; Wu Y; Wang S
Pharmacology; 2023; 108(6):540-549. PubMed ID: 37751720
[TBL] [Abstract][Full Text] [Related]
16. Case report: A rare multidrug-resistant
Zhou Q; Zhan Z; Huang F; Zhao M; Huang D; Xu J; Huang L; Xie L; Zhang A
Front Public Health; 2023; 11():1174536. PubMed ID: 37575122
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and Influencing Factors of Coagulation Dysfunction Caused by Cefoperazone/Sulbactam.
Zeng J; Zou M; Min M; Xu M
Altern Ther Health Med; 2024 Jan; ():. PubMed ID: 38290444
[TBL] [Abstract][Full Text] [Related]
18. Sulbactam/Durlobactam.
Beninger P
Clin Ther; 2024 Jan; 46(1):82-83. PubMed ID: 38065814
[No Abstract] [Full Text] [Related]
19. Retracted:
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9839734. PubMed ID: 37946955
[TBL] [Abstract][Full Text] [Related]
20. Cefoperazone/sulbactam: New composites against multiresistant gram negative bacteria?
Ku YH; Yu WL
Infect Genet Evol; 2021 Mar; 88():104707. PubMed ID: 33418147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
